Mitsuru Ikeda
Japan Advanced Institute of Science and Technology
H-index: 38
Asia-Japan
Top articles of Mitsuru Ikeda
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
LGBTQ+ 当事者に対して大学生が抱く関心内容および当事者による講演会の効果についての探索的検討 | 人間関係研究 | 池田満， イケダミツル， 平田金重， ヒラタカネシゲ， 勝山こうへい， カツヤマコウヘイ | 2023/10/31 |
対話を通じた学びを促す中等教育課外活動での生徒の態度変容とその要因 | 日本教育工学会研究報告集 | 曾渡部春香， 池田満 | 2023/10/16 |
Positive Ageing: How Can Public Libraries Help? | Proceedings of the Association for Information Science and Technology | Md Anwarul Islam Mitsuru Ikeda | 2023/10 |
A Learning Environment to Promote Awareness of the Experiential Learning Processes with Reflective Writing Support | Education Sciences | Chanakarn Kingkaew Thanaruk Theeramunkong Thepchai Supnithi Pronsiri Chatpreecha Kai Morita | 2023/1/8 |
205TiP IMPACT: Randomized, multicenter, phase III study evaluating the efficacy of immunotherapy (atezolizumab) plus anti-VEGF therapy (bevacizumab) in combination with … | Annals of Oncology | T Yamashita Y Inaba M Ikeda M Sone K Yamakado | 2023/11/1 |
Impact of bevacizumab being skipped due to adverse events of special interest for bevacizumab in patients with unresectable hepatocellular carcinoma treated with atezolizumab … | Liver Cancer | M Kudo K Tsuchiya YY Shao RS Finn PR Galle | 2023 |
153P IMbrave150: Exploratory analyses for investigating associations between overall survival (OS) and depth of response (DpR) or duration of response (DoR) in patients (pts … | Annals of Oncology | M Kudo T Yamashita RS Finn PR Galle MP Ducreux | 2023/11/1 |
OP0008 A novel site-specific pegylated IL-2 with potent and TReg-selective activity in vivo | M Ikeda S Yamaguchi M Murakami S Takaoka Y Sakaguchi | 2022/6/1 | |
IMbrave150: updated overall survival (OS) data from a global, randomized, open-label Phase III study of atezolizumab (atezo) plus bevacizumab (bev) vs sorafenib (sor) in … | ONCOLOGY RESEARCH AND TREATMENT | P Galle RS Finn S Qin M Ikeda M Ducreux | 2021 |
Electric pump | 2018/7/24 | ||
IMbrave150: updated efficacy and safety by risk status in patients (pts) receiving atezolizumab (atezo)+ bevacizumab (bev) vs sorafenib (sor) as first-line treatment for … | Zeitschrift für Gastroenterologie | P Galle RS Finn S Qin M Ikeda M Ducreux | 2021/8 |
学習目標の内省を促すセマンティクスアウェアな知的学習支援システム | 電子情報通信学会論文誌 D | 油谷知岐， 瀬田和久， 林佑樹， 池田満 | 2021/8/1 |
ラボラトリー方式の体験学習における対面形式とオンライン形式の学習成果の比較 | 人間関係研究 | 池田満， イケダミツル， 土屋耕治， ツチヤコウジ | 2021/3/31 |
Relation extraction from medical texts using semisupervised learning | MS SIRIWON TAEWIJIT Thanaruk Theeramunkong Mitsuru Ikeda | 2020 | |
「わかったつもり」 を捉える学習者モデルの構成法―セマンティクスアウェアなプレゼン教材を利用して― | 油谷知岐， 瀬田和久， 林佑樹， 池田満 | 2020 | |
169P IMbrave150: management of adverse events of special interest (AESIs) for atezolizumab (atezo) and bevacizumab (bev) in unresectable HCC | Annals of Oncology | M Kudo M Ikeda AX Zhu S Qin TY Kim | 2020/11/1 |
A Learning Experience Design for Promoting Awareness of Self-Regulated Learning Knowledge | Kai Norita Koji Tanaka Mitsuru Ikeda | 2020/9/1 | |
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2) | Zeitschrift für Gastroenterologie | M Pinter M Kudo R Finn M Morimot K Rau | 2020/5 |
Discovering cross-disciplinary concepts in multidisciplinary context through collaborative framework | International Journal of Knowledge and Systems Science (IJKSS) | Akkharawoot Takhom Sasiporn Usanavasin Thepchai Supnithi Mitsuru Ikeda Heinz Ulrich Hoppe | 2020/4/1 |
